Ainos (OTCMKTS:AIMD – Get Free Report) and GN Store Nord A/S (OTCMKTS:GGNDF – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, earnings and profitability.
Insider and Institutional Ownership
0.3% of Ainos shares are owned by institutional investors. Comparatively, 35.3% of GN Store Nord A/S shares are owned by institutional investors. 4.6% of Ainos shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
This table compares Ainos and GN Store Nord A/S’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|GN Store Nord A/S||N/A||N/A||N/A|
Earnings and Valuation
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Ainos||$2.87 million||4.45||-$14.01 million||($0.87)||-0.72|
|GN Store Nord A/S||N/A||N/A||N/A||$4.35||3.73|
GN Store Nord A/S has lower revenue, but higher earnings than Ainos. Ainos is trading at a lower price-to-earnings ratio than GN Store Nord A/S, indicating that it is currently the more affordable of the two stocks.
This is a summary of recent recommendations and price targets for Ainos and GN Store Nord A/S, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|GN Store Nord A/S||0||1||1||0||2.50|
GN Store Nord A/S beats Ainos on 7 of the 9 factors compared between the two stocks.
Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.
About GN Store Nord A/S
GN Store Nord A/S develops, manufactures, and markets audio and video communications solutions for medical, professional, and consumer technology solutions in Denmark, rest of Europe, North America, and internationally. It operates in two segments, GN Hearing and GN Audio. The GN Hearing segment produces and sells hearing instruments and products. The GN Audio segment supplies headsets, video cameras, and speakerphones for professional use and consumer products. It offers its products under the ReSound, Beltone, Interton, Jabra, BlueParrott, FalCom, and Audigy brands. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.